证券记录 · 已归档季度
ICLR
ICON Public Limited Company · Healthcare · Medical - Diagnostics & Research
12被追踪持有人
-1Δ持有人
9.48M持有股份
$1.99B报告持仓市值
+2新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -7.7% ·
股份流向 -3.0% ·
净新建仓位 -8.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +2 | 54.24M | $9.34B | +10 | −7 |
| Q1 2026 | 112 | -7 | 49.87M | $5.61B | +7 | −15 |
| Q4 2025 | 119 | -2 | 53.17M | $9.70B | +2 | −3 |
| Q3 2025 | 18 | -1 | 14.11M | $2.47B | +2 | −4 |
| Q2 2025 | 17 | +3 | 17.03M | $2.48B | +3 | — |
| Q1 2025 | 11 | -1 | 10.01M | $1.75B | +1 | −2 |
| Q4 2024 | 12 | -1 | 9.48M | $1.99B | +2 | −3 |
| Q3 2024 | 12 | -1 | 9.43M | $2.71B | +1 | −2 |
| Q2 2024 | 13 | — | 9.47M | $2.97B | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 2.93M | -12.4% | $615.20M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.93M | -12.4% | $615.20M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.12M | +574.6% | $234.08M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.12M | +574.6% | $234.08M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (被动) | 1.01M | +0.2% | $211.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 856.70K | +649.7% | $179.66M | 0.5% | ▲ Add | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 571.61K | -1.5% | $119.87M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 571.61K | -1.5% | $119.87M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (被动) | 340.78K | — | $71.46M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 225.63K | -70.9% | $47.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 125.80K | -40.7% | $26.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 88.74K | 新增 | $18.61M | 0.0% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 88.74K | 新增 | $18.61M | 0.0% | New | 1 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 84.34K | +1.1% | $17.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 19.68K | 新增 | $4.13M | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $18.61M | 0.0% |
| Marshall Wace | $18.61M | 0.0% |
| Adage Capital Partners | $4.13M | 0.0% |
已清仓
| Arrowstreet Capital | $16.17M | 曾为 0.0% |
| Fisher Asset Management | $1.58M | 曾为 0.0% |
| Capital World Investors | $380,398 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 414 持有人, 78.10M 股份, $8.66B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 11
O'Neill Julie
Director · 105 股 · $17,196
Aug 11
Murphy Ronan Martin
Director · 67 股 · $11,089
Aug 11
Murray Ciaran
Director · 280 股 · $45,562
Aug 11
Murray Ciaran
Director · 305 股 · $49,950
Aug 11
Murray Ciaran
Director · 1.88K 股 · $309,204
Aug 11
Murray Ciaran
Director · 212 股 · $35,088
Aug 11
O'Neill Julie
Director · 95 股 · $15,458
Aug 11
O'Neill Julie
Director · 642 股 · $105,590
Aug 11
O'Neill Julie
Director · 73 股 · $12,082
Aug 11
Whitaker Anne Clem
Director · 88 股 · $14,319
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — Invesco Ltd.
Aug 06
SC 13G/A — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据